These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 32341551)

  • 21. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
    Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R
    Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension.
    Paulin R; Courboulin A; Barrier M; Bonnet S
    J Mol Med (Berl); 2011 Nov; 89(11):1089-101. PubMed ID: 21761156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
    Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
    Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders.
    Saida S
    Curr Treat Options Oncol; 2017 Jul; 18(7):41. PubMed ID: 28580501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles for KRAS in pancreatic tumor development and progression.
    di Magliano MP; Logsdon CD
    Gastroenterology; 2013 Jun; 144(6):1220-9. PubMed ID: 23622131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells.
    Zecchin D; Arena S; Martini M; Sassi F; Pisacane A; Di Nicolantonio F; Bardelli A
    Hum Mutat; 2013 Feb; 34(2):330-7. PubMed ID: 23292961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mini-driver model of polygenic cancer evolution.
    Castro-Giner F; Ratcliffe P; Tomlinson I
    Nat Rev Cancer; 2015 Nov; 15(11):680-5. PubMed ID: 26456849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice.
    Schessl C; Rawat VP; Cusan M; Deshpande A; Kohl TM; Rosten PM; Spiekermann K; Humphries RK; Schnittger S; Kern W; Hiddemann W; Quintanilla-Martinez L; Bohlander SK; Feuring-Buske M; Buske C
    J Clin Invest; 2005 Aug; 115(8):2159-68. PubMed ID: 16025155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice.
    Foth M; Ahmad I; van Rhijn BW; van der Kwast T; Bergman AM; King L; Ridgway R; Leung HY; Fraser S; Sansom OJ; Iwata T
    J Pathol; 2014 Jun; 233(2):148-58. PubMed ID: 24519156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PIG3: a novel link between oxidative stress and DNA damage response in cancer.
    Kotsinas A; Aggarwal V; Tan EJ; Levy B; Gorgoulis VG
    Cancer Lett; 2012 Dec; 327(1-2):97-102. PubMed ID: 22178897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro transformation models: modeling human cancer.
    Heeg S; Doebele M; von Werder A; Opitz OG
    Cell Cycle; 2006 Mar; 5(6):630-4. PubMed ID: 16582608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracing the cellular origin of cancer.
    Blanpain C
    Nat Cell Biol; 2013 Feb; 15(2):126-34. PubMed ID: 23334500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cancer cell metabolism.
    Cairns RA; Harris IS; Mak TW
    Nat Rev Cancer; 2011 Feb; 11(2):85-95. PubMed ID: 21258394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations.
    Sawai Y; Kodama Y; Shimizu T; Ota Y; Maruno T; Eso Y; Kurita A; Shiokawa M; Tsuji Y; Uza N; Matsumoto Y; Masui T; Uemoto S; Marusawa H; Chiba T
    Cancer Res; 2015 Aug; 75(16):3292-301. PubMed ID: 26113087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciliary biology: understanding the cellular and genetic basis of human ciliopathies.
    Cardenas-Rodriguez M; Badano JL
    Am J Med Genet C Semin Med Genet; 2009 Nov; 151C(4):263-80. PubMed ID: 19876935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
    Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
    Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethality.
    Dhomen N; Da Rocha Dias S; Hayward R; Ogilvie L; Hedley D; Delmas V; McCarthy A; Henderson D; Springer CJ; Pritchard C; Larue L; Marais R
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):112-20. PubMed ID: 20002887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transduction pathways activated by RET oncoproteins in PC12 pheochromocytoma cells.
    Xing S; Furminger TL; Tong Q; Jhiang SM
    J Biol Chem; 1998 Feb; 273(9):4909-14. PubMed ID: 9478934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications.
    Zhu C; Wei Y; Wei X
    Mol Cancer; 2019 Nov; 18(1):153. PubMed ID: 31684958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.